Amgen Inc. (NASDAQ:AMGN) Q3 2018 Results Earnings Conference Call October 30, 2018 5:00 PM ET
Executives
Arvind Sood - VP, IR
Robert Bradway - Chairman and CEO
David Meline - CFO
Murdo Gordon - Head, Global Commercial Operations
David Reese - EVP, R&D
Tony Hooper - EVP, Global Commercial Operations
Analysts
Matthew Harrison - Morgan Stanley
Geoffrey Meacham - Barclays
Ying Huang - Bank of America Merrill Lynch
Terence Flynn - Goldman Sachs
Chris Raymond - Piper Jaffray
Phil Nadeau - Cowen & Company
Robyn Karnauskas - Citi
Michael Yee - Jefferies
Geoffrey Porges - Leerink
Ronny Gal - Bernstein
Umer Raffat - Evercore ISI
Kennen MacKay - RBC Capital Markets
Cory Kasimov - JPMorgan
Carter Gould - UBS
Alethia Young - Cantor Fitzgerald
Salim Syed - Mizuho Securities
Brian Skorney - Robert W. Baird
Operator
My name is Ian and I will be your conference facilitator today for Amgen's Third Quarter 2018 Financial Results Conference Call. [Operator Instructions]
I would now like to introduce Arvind Sood, Vice President of Investor Relations. Mr. Sood, you may now begin.
Arvind Sood
Excellent. Thanks Ian. Good afternoon, everybody. Thanks for joining us today. We have a lot of ground to cover, so I'll keep my comments brief.
Continued execution, launch progress, and pipeline advancement are some key themes that come to mind as I think about our third quarter results. To elaborate on these themes and more, I'm joined today by Bob Bradway, our Chairman and CEO. After Bob's strategic review, our CFO David Meline will review our financial results for the third quarter and provide updated guidance for 2018. Also joining us today is Tony Hooper, and then you'll get to hear from Murdo Gordon, our newly appointed Head of Global Commercial Operations. Following Murdo's review of product performance, our Head of R&D, David Reese will provide a pipeline update. We will use slides to
- Read more current AMGN analysis and news
- View all earnings call transcripts